The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: using clinical judgement over treatment criteria.
A B Apolo
,
J Bellmunt
,
L Cordes
,
S Gupta
,
T Powles
,
J E Rosenberg
,
M S Van Der Heijden
More about this publication
ESMO open
Volume
9
Issue nr.
9
Pages
103725
Publication date
01-09-2024
Full text links
Publisher website (DOI)
10.1016/j.esmoop.2024.103725
Europe PubMed Central
39236601
Pubmed
39236601